{"title":"从玻璃化卵母细胞衍生的玻璃化囊胚中获得健康的同卵双胞胎,以及用于冷冻人类卵母细胞和囊胚的高效玻璃化方法","authors":"Shaohua Huang, Christina Miao, Sammy Sun, S. Toma","doi":"10.11648/J.AJBIO.20200805.12","DOIUrl":null,"url":null,"abstract":"We used simplified oocyte/embryo vitrification and warming protocols (Irvine Scientific) combined with vitristraws (SciTech Invention) to freeze and thaw human oocytes and blastsocysts. Throughout the year of 2014, twelve recipients were transferred embryos developed from vitrified donor oocytes, and fourteen recipients were transferred embryos developed from fresh donor oocytes at the North Carolina center for reproductive medicine (NCCRM). There were no statistically significant differences in donor age (25.9 ± 3.6 vs 24.9 ± 3.2) and recipient age (43.0 ± 5.4 vs 41.4 ± 6.8), fertilization rates (86.2% vs 87.0%), blastocyst development rates (50.0% vs 53.8%), number of embryo transferred (1.7 ± 0.8 vs 1.9 ± 0.4), clinical pregnancy rates per transfer (75.0% vs 71.4%) and live birth rates per transfer (66.7% vs 57.1%) between vitrified and fresh oocyte cycles, respectively. The results demonstrate that vitrification techniques can be used to cryopreserve human oocytes for future use. We are also reporting the live birth of healthy monozygotic twins resulted from a re-vitrified blastocyst derived from a vitrified oocyte. Oocytes from a 30-year-old donor were vitrified in vitristraws. Seven out of eight oocytes survived after thawing on November 16, 2013. Those seven oocytes were inseminated by intracytoplasmic sperm injection (ICSI) at about 2 hours post thawing. All seven oocytes were tested as fertilized by pronuclear check at 18 hours after ICSI. Those fertilized oocytes showed normal cleavage on day 2 and day 3. Four of them developed to blastsocysts by culturing in continuous single culture medium in a tri-gas incubator for 5 days. Two blastsocysts were transferred to a 43-year-old recipient, but that did not result in a pregnancy. The other two blastsocysts were re-vitrified in a vitristraw. The re-vitrified blastsocysts were thawed and then transferred to the same recipient on May 8, 2014. The patient achieved a normal pregnancy on her second transfer. On June 14, 2014, an ultrasound scan detected two heartbeats in one gestational sac. Two healthy monozygotic boys (weighing 2466g and 2353g) were born on January 13, 2015. To our knowledge, this is the first report of monozygotic twins born from an embryo by twice vitrification at oocyte and blastocyst stage.","PeriodicalId":7478,"journal":{"name":"American Journal of BioScience","volume":"34 1","pages":"132"},"PeriodicalIF":0.0000,"publicationDate":"2020-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Healthy Monozygotic Twins Born from a Vitrified Blastocyst Derived from a Vitrified Oocyte, and a Highly Efficient Vitrification for Freezing Human Oocytes and Blastsocysts\",\"authors\":\"Shaohua Huang, Christina Miao, Sammy Sun, S. Toma\",\"doi\":\"10.11648/J.AJBIO.20200805.12\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"We used simplified oocyte/embryo vitrification and warming protocols (Irvine Scientific) combined with vitristraws (SciTech Invention) to freeze and thaw human oocytes and blastsocysts. Throughout the year of 2014, twelve recipients were transferred embryos developed from vitrified donor oocytes, and fourteen recipients were transferred embryos developed from fresh donor oocytes at the North Carolina center for reproductive medicine (NCCRM). There were no statistically significant differences in donor age (25.9 ± 3.6 vs 24.9 ± 3.2) and recipient age (43.0 ± 5.4 vs 41.4 ± 6.8), fertilization rates (86.2% vs 87.0%), blastocyst development rates (50.0% vs 53.8%), number of embryo transferred (1.7 ± 0.8 vs 1.9 ± 0.4), clinical pregnancy rates per transfer (75.0% vs 71.4%) and live birth rates per transfer (66.7% vs 57.1%) between vitrified and fresh oocyte cycles, respectively. The results demonstrate that vitrification techniques can be used to cryopreserve human oocytes for future use. We are also reporting the live birth of healthy monozygotic twins resulted from a re-vitrified blastocyst derived from a vitrified oocyte. Oocytes from a 30-year-old donor were vitrified in vitristraws. Seven out of eight oocytes survived after thawing on November 16, 2013. Those seven oocytes were inseminated by intracytoplasmic sperm injection (ICSI) at about 2 hours post thawing. All seven oocytes were tested as fertilized by pronuclear check at 18 hours after ICSI. Those fertilized oocytes showed normal cleavage on day 2 and day 3. Four of them developed to blastsocysts by culturing in continuous single culture medium in a tri-gas incubator for 5 days. Two blastsocysts were transferred to a 43-year-old recipient, but that did not result in a pregnancy. The other two blastsocysts were re-vitrified in a vitristraw. The re-vitrified blastsocysts were thawed and then transferred to the same recipient on May 8, 2014. The patient achieved a normal pregnancy on her second transfer. On June 14, 2014, an ultrasound scan detected two heartbeats in one gestational sac. Two healthy monozygotic boys (weighing 2466g and 2353g) were born on January 13, 2015. To our knowledge, this is the first report of monozygotic twins born from an embryo by twice vitrification at oocyte and blastocyst stage.\",\"PeriodicalId\":7478,\"journal\":{\"name\":\"American Journal of BioScience\",\"volume\":\"34 1\",\"pages\":\"132\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-09-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of BioScience\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.11648/J.AJBIO.20200805.12\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of BioScience","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11648/J.AJBIO.20200805.12","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
我们使用简化的卵母细胞/胚胎玻璃化和加热方案(Irvine Scientific)结合玻璃吸管(sciitech Invention)来冷冻和解冻人卵母细胞和囊胚。2014年,在北卡罗来纳生殖医学中心(NCCRM), 12名受者接受了玻璃化供体卵母细胞发育的胚胎移植,14名受者接受了新鲜供体卵母细胞发育的胚胎移植。供体年龄(25.9±3.6 vs 24.9±3.2)和受体年龄(43.0±5.4 vs 41.4±6.8)、受精率(86.2% vs 87.0%)、囊胚发育率(50.0% vs 53.8%)、移植胚胎数(1.7±0.8 vs 1.9±0.4)、每次移植临床妊娠率(75.0% vs 71.4%)和每次移植活产率(66.7% vs 57.1%)在玻璃化卵母细胞周期和新鲜卵母细胞周期之间差异均无统计学意义。结果表明,玻璃化技术可用于冷冻保存人类卵母细胞,以备将来使用。我们也报告了健康的同卵双胞胎是由玻璃化卵母细胞衍生的再玻璃化囊胚导致的。将一名30岁供者的卵母细胞放在玻璃板中玻璃化。2013年11月16日,8个卵母细胞中有7个在解冻后存活。7个卵母细胞在解冻后约2小时通过胞浆内单精子注射(ICSI)进行受精。所有7个卵母细胞在ICSI后18小时接受核原检查。受精卵在第2天和第3天显示正常的卵裂。其中4只在三气培养箱的连续单一培养基中培养5天,发育成囊胚。两个囊胚被移植给一名43岁的接受者,但没有导致怀孕。另外两个胚泡在玻璃吸管中重新玻璃化。2014年5月8日,将重新玻璃化的胚泡解冻后移植给同一受体。患者在第二次移植时实现了正常妊娠。2014年6月14日,超声扫描在一个妊娠囊中检测到两个心跳。2015年1月13日,两名健康的同卵男婴(体重分别为2466克和2353克)出生。据我们所知,这是第一个在卵母细胞和囊胚阶段通过两次玻璃化胚胎出生的同卵双胞胎的报告。
Healthy Monozygotic Twins Born from a Vitrified Blastocyst Derived from a Vitrified Oocyte, and a Highly Efficient Vitrification for Freezing Human Oocytes and Blastsocysts
We used simplified oocyte/embryo vitrification and warming protocols (Irvine Scientific) combined with vitristraws (SciTech Invention) to freeze and thaw human oocytes and blastsocysts. Throughout the year of 2014, twelve recipients were transferred embryos developed from vitrified donor oocytes, and fourteen recipients were transferred embryos developed from fresh donor oocytes at the North Carolina center for reproductive medicine (NCCRM). There were no statistically significant differences in donor age (25.9 ± 3.6 vs 24.9 ± 3.2) and recipient age (43.0 ± 5.4 vs 41.4 ± 6.8), fertilization rates (86.2% vs 87.0%), blastocyst development rates (50.0% vs 53.8%), number of embryo transferred (1.7 ± 0.8 vs 1.9 ± 0.4), clinical pregnancy rates per transfer (75.0% vs 71.4%) and live birth rates per transfer (66.7% vs 57.1%) between vitrified and fresh oocyte cycles, respectively. The results demonstrate that vitrification techniques can be used to cryopreserve human oocytes for future use. We are also reporting the live birth of healthy monozygotic twins resulted from a re-vitrified blastocyst derived from a vitrified oocyte. Oocytes from a 30-year-old donor were vitrified in vitristraws. Seven out of eight oocytes survived after thawing on November 16, 2013. Those seven oocytes were inseminated by intracytoplasmic sperm injection (ICSI) at about 2 hours post thawing. All seven oocytes were tested as fertilized by pronuclear check at 18 hours after ICSI. Those fertilized oocytes showed normal cleavage on day 2 and day 3. Four of them developed to blastsocysts by culturing in continuous single culture medium in a tri-gas incubator for 5 days. Two blastsocysts were transferred to a 43-year-old recipient, but that did not result in a pregnancy. The other two blastsocysts were re-vitrified in a vitristraw. The re-vitrified blastsocysts were thawed and then transferred to the same recipient on May 8, 2014. The patient achieved a normal pregnancy on her second transfer. On June 14, 2014, an ultrasound scan detected two heartbeats in one gestational sac. Two healthy monozygotic boys (weighing 2466g and 2353g) were born on January 13, 2015. To our knowledge, this is the first report of monozygotic twins born from an embryo by twice vitrification at oocyte and blastocyst stage.